ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Psychiatry

Top Psychiatry Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN GRELECKI MD

Psychiatry

10,686

$1.36M

469
81 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $135

VICENTE LIM MD

Psychiatry

10,501

$1.64M

283
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$156
Average prescription price

Avg: $135

CLAUDIO DICOVSKIY MD

Psychiatry

8,258

$1.05M

596
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $135

JOSE GOMEZ-RIVERA M.D.

Psychiatry

7,553

$870K

465
162 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

42%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$115
Average prescription price

Avg: $135

KATE HALLER MD

Psychiatry

7,127

$764K

308
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $135

DANIEL SANCHEZ M.D.

Psychiatry

6,700

$681K

516
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $135

KYLE STIFFLER MD

Psychiatry

6,605

$665K

308
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $135

SAUL GORMAN MD

Psychiatry

6,464

$814K

339
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$126
Average prescription price

Avg: $135

ROBERT BERKOWITZ M.D.

Psychiatry

6,439

$1.19M

361
128 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 26%

$186
Average prescription price

Avg: $135

RAJKUMAR SINGH MD

Psychiatry

6,418

$921K

332
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$144
Average prescription price

Avg: $135

DINESH PATEL M.D

Psychiatry

6,339

$1.26M

384
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 26%

$199
Average prescription price

Avg: $135

SAHAR SHAFEY M.D.

Psychiatry

6,273

$515K

210
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $135

LAMBERTO TAN M.D.

Psychiatry

6,178

$1.19M

333
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$193
Average prescription price

Avg: $135

PEDRO GARCIA M.D.

Psychiatry

6,119

$848K

380
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$139
Average prescription price

Avg: $135

ANDREA NAGY-HALLETT M.D.

Psychiatry

5,914

$862K

304
102 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 26%

$146
Average prescription price

Avg: $135

DENNIS LEONE M.D.

Psychiatry

5,638

$874K

247
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 26%

$155
Average prescription price

Avg: $135

AIJAZ NANJIANI M.D.

Psychiatry

5,637

$697K

287
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$124
Average prescription price

Avg: $135

CARMELO PINGOL MD

Psychiatry

5,581

$877K

277
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $135

TATYANA BELINSKY MD

Psychiatry

5,489

$884K

353
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$161
Average prescription price

Avg: $135

STEVEN SARNER M.D.

Psychiatry

5,382

$923K

332
59 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 26%

$172
Average prescription price

Avg: $135

LAWRENCE CLINTON M.D.

Psychiatry

5,223

$584K

271
119 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $135

ANTHONY GREEN MD

Psychiatry

5,150

$924K

299
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 26%

$179
Average prescription price

Avg: $135

FRANK ABENANTE M.D.

Psychiatry

5,147

$573K

245
124 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 26%

$111
Average prescription price

Avg: $135

PANKAJ BHANDARI M.D.

Psychiatry

5,080

$767K

256
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$151
Average prescription price

Avg: $135

FRANK SANTOS MD

Psychiatry

5,048

$560K

487
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 26%

$111
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank